Angela Ahrendts, the newly appointed retail chief of Apple Inc. (NASDAQ:AAPL) has been granted with 113,334 restricted stock units (RSUs) based on a regulatory filing with the Securities and Exchange Commission (SEC). The restricted stock units awarded to Ahrendts is worth approximately $68 million based on the closing price of the shares of Apple Inc (NASDAQ:AAPL) at $600.96 per share on Monday. It is the first time for the shares of the iPhone maker to reach a $600 stock price since October 2012. Ahrendts replaced John Browett who resigned as head of the retail unit at Apple Inc (NASDAQ:AAPL) around that period. Apple Inc.(NASDAQ:AAPL) shares after opening at $590.14 moved to $601.00 on last trade day and at the end of the day closed at $600.96. Company price to sales ratio in past twelve months was calculated as 2.94 and price to cash ratio as 12.52. Apple Inc.(NASDAQ:AAPL) showed a positive weekly performance of 1.16%.
Exxon Mobil (NYSE:XOM) VP William Colton sold 16,240 shares of the company’s stock on the open market in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $102.27, for a total value of $1,660,864.80. Following the sale, the vice president now directly owns 170,418 shares in the company, valued at approximately $17,428,649. Exxon Mobil Corporation (NYSE:XOM) shares advanced 0.88% in last trading session and ended the day on $102.91. XOM return on equity ratio is recorded as 24.90% and its return on assets is 12.20%. Exxon Mobil Corporation (NYSE:XOM) yearly performance is 17.52%.
The Swiss-based Novartis AG (ADR) (NYSE:NVS) was due to acquire the ownership of Jerusalem-based Gamida Cell, a stem cell technology company. However, that transaction is off, according to the parent companies of Gamida. Novartis was planned to take over the full ownership of Gamida in a sale transaction valued at $600 million. Gamida is owned by among others Teva Pharmaceutical Industries, Elbit Medical and Clal Biotechnology. Novartis, a Swiss multinational drug company, would have made an upfront payment of $170 million for the stem cell technology business. But that will not happen, and the next line of action is not known. Novartis AG (ADR)(NYSE:NVS) shares moved up 0.47% in last trading session and was closed at $87.77, while trading in range of $ 86.95 – 87.82. Novartis AG (ADR)(NYSE:NVS) year to date (YTD) performance is 12.87%.
Facebook Inc (NASDAQ:FB) allows advertisers to put video ads on the brands’ pages. The company is gearing up to roll out auto-play video ads that can target specific demographics or run across the site. And its 1.2 billion user base ensures that the platform has pretty much any demographic advertisers want. In December, the social networking giant tested video ads for the movie Divergent. Soon, the company will start running these auto-plays ads to its entire user base. Facebook Inc (NASDAQ:FB) weekly performance is 9.05%. On last trading day company shares ended up $61.22. Facebook Inc (NASDAQ:FB) distance from 50-day simple moving average (SMA50) is -4.29%. Analysts mean target price for the company is $77.76.
Leave a Reply